These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 10634820

  • 1. A single amino acid deletion in the carboxy terminal of apolipoprotein A-I impairs lipid binding and cellular interaction.
    Huang W, Sasaki J, Matsunaga A, Han H, Li W, Koga T, Kugi M, Ando S, Arakawa K.
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):210-6. PubMed ID: 10634820
    [Abstract] [Full Text] [Related]

  • 2. Recombinant proapoA-I(Lys107del) shows impaired lipid binding associated with reduced binding to plasma high density lipoprotein.
    Huang W, Matsunaga A, Li W, Han H, Hoang A, Kugi M, Koga T, Sviridov D, Fidge N, Sasaki J.
    Atherosclerosis; 2001 Nov; 159(1):85-91. PubMed ID: 11689210
    [Abstract] [Full Text] [Related]

  • 3. A novel mutant, ApoA-I nichinan (Glu235-->0), is associated with low HDL cholesterol levels and decreased cholesterol efflux from cells.
    Han H, Sasaki J, Matsunaga A, Hakamata H, Huang W, Ageta M, Taguchi T, Koga T, Kugi M, Horiuchi S, Arakawa K.
    Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1447-55. PubMed ID: 10364075
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. High level secretion of wild-type and mutant forms of human proapoA-I using baculovirus-mediated Sf-9 cell expression.
    Sorci-Thomas MG, Parks JS, Kearns MW, Pate GN, Zhang C, Thomas MJ.
    J Lipid Res; 1996 Mar; 37(3):673-83. PubMed ID: 8728328
    [Abstract] [Full Text] [Related]

  • 8. The carboxyl-terminal hydrophobic residues of apolipoprotein A-I affect its rate of phospholipid binding and its association with high density lipoprotein.
    Laccotripe M, Makrides SC, Jonas A, Zannis VI.
    J Biol Chem; 1997 Jul 11; 272(28):17511-22. PubMed ID: 9211897
    [Abstract] [Full Text] [Related]

  • 9. Deletion of the C-terminal domain of apolipoprotein A-I impairs cell surface binding and lipid efflux in macrophage.
    Burgess JW, Frank PG, Franklin V, Liang P, McManus DC, Desforges M, Rassart E, Marcel YL.
    Biochemistry; 1999 Nov 02; 38(44):14524-33. PubMed ID: 10545174
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Deletion of single amino acid E235 affects the structure and lipid interaction of human apolipoprotein A-I C-terminal peptides.
    Tanaka T, Tanaka M, Sugiura M, Kawakami T, Aimoto S, Saito H.
    Chem Pharm Bull (Tokyo); 2009 May 02; 57(5):499-503. PubMed ID: 19420782
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Interaction of reconstituted high density lipoprotein discs containing human apolipoprotein A-I (ApoA-I) variants with murine adipocytes and macrophages. Evidence for reduced cholesterol efflux promotion by apoA-I(Pro165-->Arg).
    von Eckardstein A, Castro G, Wybranska I, Theret N, Duchateau P, Duverger N, Fruchart JC, Ailhaud G, Assmann G.
    J Biol Chem; 1993 Feb 05; 268(4):2616-22. PubMed ID: 8428938
    [Abstract] [Full Text] [Related]

  • 14. Apolipoprotein A-I (R151C)Paris is defective in activation of lecithin: cholesterol acyltransferase but not in initial lipid binding, formation of reconstituted lipoproteins, or promotion of cholesterol efflux.
    Daum U, Langer C, Duverger N, Emmanuel F, Benoit P, Denèfle P, Chirazi A, Cullen P, Pritchard PH, Bruckert E, Assmann G, von Eckardstein A.
    J Mol Med (Berl); 1999 Aug 05; 77(8):614-22. PubMed ID: 10543393
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Structural and functional properties of V156K and A158E mutants of apolipoprotein A-I in the lipid-free and lipid-bound states.
    Han JM, Jeong TS, Lee WS, Choi I, Cho KH.
    J Lipid Res; 2005 Mar 05; 46(3):589-96. PubMed ID: 15716588
    [Abstract] [Full Text] [Related]

  • 17. Binding of high density lipoprotein (HDL) and discoidal reconstituted HDL to the HDL receptor scavenger receptor class B type I. Effect of lipid association and APOA-I mutations on receptor binding.
    Liadaki KN, Liu T, Xu S, Ishida BY, Duchateaux PN, Krieger JP, Kane J, Krieger M, Zannis VI.
    J Biol Chem; 2000 Jul 14; 275(28):21262-71. PubMed ID: 10801839
    [Abstract] [Full Text] [Related]

  • 18. Importance of central alpha-helices of human apolipoprotein A-I in the maturation of high-density lipoproteins.
    Frank PG, N'Guyen D, Franklin V, Neville T, Desforges M, Rassart E, Sparks DL, Marcel YL.
    Biochemistry; 1998 Sep 29; 37(39):13902-9. PubMed ID: 9753480
    [Abstract] [Full Text] [Related]

  • 19. Characterization of human apolipoprotein A-I expressed in Escherichia coli.
    Bergeron J, Frank PG, Emmanuel F, Latta M, Zhao Y, Sparks DL, Rassart E, Denèfle P, Marcel YL.
    Biochim Biophys Acta; 1997 Jan 21; 1344(2):139-52. PubMed ID: 9030191
    [Abstract] [Full Text] [Related]

  • 20. Structural and functional properties of full-length and truncated human proapolipoprotein AI expressed in escherichia coli.
    Pyle LE, Sawyer WH, Fujiwara Y, Mitchell A, Fidge NH.
    Biochemistry; 1996 Sep 17; 35(37):12046-52. PubMed ID: 8810909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.